Industry · Health Care
Pharma & Biotech
11 companies · sorted by market cap · Today +2.48% · 83% of the Health Care sector
Rank by
| # | Company | Market Cap | Price | Today | 7D | Country |
|---|---|---|---|---|---|---|
1 |  Eli LillyLLY Oct 29 | $1.34T | $1,423.00 | +3.61% | +11.84% | USA |
2 |  Johnson & JohnsonJNJ Oct 13 | $665B | $276.49 | +0.48% | +4.87% | USA |
3 |  AbbVieABBV Oct 30 | $522B | $295.31 | +1.57% | +3.53% | USA |
4 |  RocheRHHBY | $393B | $61.20 | +0.59% | +0.05% | Switzerland |
5 |  MerckMRK Oct 29 | $371B | $150.40 | +2.80% | +3.48% | USA |
6 |  NovartisNVS Oct 27 | $309B | $161.89 | +0.53% | +7.11% | Switzerland |
7 |  AstraZenecaAZN Oct 30 | $291B | $187.22 | +7.28% | +9.27% | UK |
8 |  AmgenAMGN Nov 3 | $254B | $469.81 | +2.00% | +7.05% | USA |
9 |  Gilead SciencesGILD Oct 29 | $214B | $172.19 | +3.99% | +10.43% | USA |
10 |  PfizerPFE Nov 3 | $174B | $30.53 | +1.94% | +1.68% | USA |
11 |  Bristol-Myers SquibbBMY Oct 29 | $129B | $62.91 | +2.46% | +2.31% | USA |
Changes end at the last regular-session close; after-hours moves are not included. Updated 1:52 PM ET